Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

Also called NCT02284048

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02284048
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02284048. Randomized; single masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2016-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Ticagrelor on Adenosine-Induced Coronary Flow Reserve in Patients With Microvascular Angina
Condition
Microvascular Angina
Intervention (Drug)
ticagrelor
Lead sponsor
Second Xiangya Hospital of Central South University (class: other)

Record details

Record id
cardio:ct-nct02284048
Content hash
f5b6bc3ba0ba68cd8c9715e631756f1d70f5f9d470fa02cc9a0de635199172cd